Evidence map›Paper›PMID 40349850›Full record

ReviewNeurotoxicology2025

Cumulative risk assessment as the pathway to public health protection for behavioral neurotoxicity.

Deborah A Cory-Slechta, Cynthia J Downs, Marissa Sobolewski

Abstract readReview
In one paragraph

Review in Neurotoxicology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Deborah A Cory-SlechtaDepartment of Environmental Medicine, University of Rochester Medical Center, Rochester, NY 14642, United States. Electronic address: deborah_cory-slechta@urmc.rochester.edu.
Cynthia J DownsDepartment of Environmental Biology, SUNY College of Environmental Science and Forestry, Syracuse, NY 13210, United States.
Marissa SobolewskiDepartment of Environmental Medicine, University of Rochester Medical Center, Rochester, NY 14642, United States. Electronic address: marissa_sobolewski@urmc.rochester.edu.

Funding

VISUAL INDICES OF NEUROTOXICITYP30ES001247 · NIEHS · UNIVERSITY OF ROCHESTER · PI Martha Susiarjo · 1985 to 2026
$42.8M
Early Life Air Pollution Exposures as a Risk Factor for Neurodevelopmental DisordersR35ES031689 · NIEHS · UNIVERSITY OF ROCHESTER · PI CORY-SLECHTA, DEBORAH A · 2021 to 2025
$6.7M
Air Pollution, Elevated Brain Iron and Alzheimer's DiseaseR01ES032260 · NIEHS · UNIVERSITY OF ROCHESTER · PI CORY-SLECHTA, DEBORAH A · 2020 to 2025
$2.4M
Air Pollution-Derived Iron Exposure, Poverty-Related Stress, and Alzheimer's Disease RiskRF1NS139187 · NINDS · UNIVERSITY OF ROCHESTER · PI TERRY, MARISSA SOBOLEWSKI · 2024 to 2024
$1.6M
Endocrine Disrupting Chemicals and Male-biased Neurobehavioral DisordersR01ES034829 · NIEHS · UNIVERSITY OF ROCHESTER · PI Marissa Sobolewski Terry · 2023 to 2026
$1.5M
NIEHS NIH HHS P30 ES001247NIEHS NIH HHS R01 ES032260NIEHS NIH HHS R01 ES034829NIEHS NIH HHS R35 ES031689NINDS NIH HHS RF1 NS139187
6 · The paper itself

Abstract

The formulation of adverse outcome pathways (AOPs) based on high-throughput in vitro new approach methods linking biochemical/mechanistic data with an apical endpoint considered an adverse outcome (AO), is increasingly proposed to accelerate the process of risk assessment for environmental chemical exposures. While a laudable goal, this approach ignores the extensive evidence demonstrating context-dependence of neurotoxicological consequences, including behavioral toxicity of chemical exposures. Such contextual modifiers can include environmental conditions (poverty, psychosocial stress, behavioral experience/history), physiological conditions (sex, period of exposure, nutritional status, brain region, exposure parameters), and genetic background. Context dependence represents a serious omission for AOP formulation because an environmental context can alter a chemical's molecular targets, or potentially enhance toxicity through interactions with other contextual conditions, thus leading to potential underestimation of neurological risks due to such exposures. The integrative physiological basis of AOs requires cumulative risk assessments that model environmental contexts across scales of biology, i.e., integration and testing in whole-animal models. AOPs contribute to the derivation of cumulative risk considerations regarding factors to incorporate into cumulative risk assessments by defining risk factors with shared biological targets. Epidemiological and animal model studies can provide information to prioritize interactive effects of greatest magnitude. Additionally, a focus on how a single risk factor in different physiological contexts may attribute risk across multiple neurologic conditions, rather than to a single unique condition, would provide broader public health protection. Realistic acknowledgement of context-dependence is requisite to understanding both the etiological basis of neurological diseases and disorders and to human health protection.

Indexed as

Adverse Outcome PathwaysEnvironmental ExposureNeurotoxicity SyndromesPublic HealthAnimalsHumansRisk AssessmentAdverse outcome pathwaysBehavioral toxicologyCumulative riskNeurotoxicology

Identifiers

PMID40349850
PMCPMC12140882

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.